Here you can find the archive of all Press Releases prior to 2021
Filter by date:
Showing 973 press releases before 2021
-
Forxiga approved in the EU for heart failure
-
Year-to-date and Q3 2020 results
-
Atacand to be divested to Cheplapharm in more than 70 countries
-
Fasenra eliminated oral corticosteroid use in a majority of OCS-dependent patients with asthma in PONENTE Phase IIIb trial
-
Enhertu granted Priority Review in the US for the treatment of HER2-positive metastatic gastric cancer
-
Forxiga cardiovascular outcomes benefit approved in China
-
FDA authorises restart of the COVID-19 AZD1222 vaccine US Phase III trial
-
Farxiga DAPA-CKD Phase III trial reduced worsening of kidney function, risk of cardiovascular or renal death in patients with chronic kidney disease, irrespective of underlying cause
-
AstraZeneca advances leadership in renal disease with more than 80 abstracts at ASN Kidney Week 2020 Reimagined
-
Tagrisso granted Priority Review in the US for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
